COMMUNIQUÉS West-GlobeNewswire

Medovex Corporation Releases Letter to Shareholders

20/11/2017 - 14:00

ATLANTA, Nov. 20, 2017 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB:MDVX) ("Medovex" or the "Company"), the developer of the DenerveX® System, a new and novel device designed for enduring relief of Facet Joint Syndrome [...]

CMS Releases 2018 Clinical Laboratory Fee Schedule

20/11/2017 - 14:00

BRISBANE, Calif., Nov. 20, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA ), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]

Delcath Enhances Board of Directors With Appointment of Industry Veteran, Dr. Simon Pedder

20/11/2017 - 14:00

NEW YORK, Nov. 20, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that Simon Pedder, Ph.D., a [...]

Diffusion Pharmaceuticals Regains Compliance with Nasdaq Capital Market Minimum Equity Rule

20/11/2017 - 14:00

CHARLOTTESVILLE, Va., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN ) (“Diffusion” or “the Company”), is a clinical-stage biotechnology company focused on extending the life expectancy [...]

Loop Industries Announces Uplisting to The NASDAQ Global Market

20/11/2017 - 14:00

MONTREAL, Nov. 20, 2017 (GLOBE NEWSWIRE) -- Loop™ Industries, Inc. (NASDAQ: LOOP ), a leader in sustainably produced polyethylene terephthalate (Polyester/PET) resin, today announced that its shares of common stock were [...]

ESMO Asia 2017: Oraxol (oral paclitaxel, Athenex) Can Achieve Similar Exposure to IV Paclitaxel in Cancer Patients

20/11/2017 - 14:00

BUFFALO, N.Y., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

TESARO’s Mary Lynne Hedley and Lonnie Moulder Named EY National Entrepreneurs of the Year®

20/11/2017 - 14:00

WALTHAM, Mass., Nov. 20, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc., an oncology-focused biopharmaceutical company, is proud to announce that co-founders Lonnie Moulder, CEO, and Mary Lynne Hedley, Ph.D., President and COO, [...]

Celsion Announces Publication of the Study of ThermoDox® + Ultrasound, “TARDOX Study Protocol” in the Journal of Therapeutic Ultrasound

20/11/2017 - 14:00

Collaboration with University of Oxford to Execute a Clinical Trial Using Focused Ultrasound and ThermoDox® for Primary and Metastatic Liver Cancer Presentation of TARDOX Study Phase I Findings at the Upcoming RSNA 2017 [...]

AxoGen Advances its Platform for Nerve Repair at Annual Analyst and Investor Day

20/11/2017 - 14:00

Company Announces Expanded Application to Address Breast Reconstruction Neurotization Following Mastectomy Company Will Continue Developing its Portfolio of Products Toward Future Applications Including the Surgical [...]

Premier Biomedical’s CEO, William A. Hartman, Returns to Uptick Network “Stock Day” for an Update on Latest Company Developments

20/11/2017 - 14:00

Dallas, TX, Nov. 20, 2017 (GLOBE NEWSWIRE) -- Uptick Newswire announces the return of Mr. William A. Hartman, President & CEO of Premier Biomedical Inc. ( OTCQB: BIEI , the “Company”) on the Uptick Network “Stock [...]

IBEX Reports Results for the Year Ended July 31, 2017

20/11/2017 - 14:00

MONTREAL, Nov. 20, 2017 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX-V: IBT ) today reported its financial results for the fiscal year ended July 31, 2017. “I am pleased to report that [...]

India Globalization Capital Reports Second Quarter 2018 Financial Results and Operational Highlights

20/11/2017 - 14:00

BETHESDA, Md., Nov. 20, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC), today reported financial results for the second quarter ended September 30, 2017 and provided an overview of recent [...]

Inovalon and the University of Maryland Center for Health Information & Decision Systems Collaborate on Machine Learning and Neural Network Applications

20/11/2017 - 13:55

BOWIE, Md., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV ), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based [...]

Optinose to Report Third Quarter 2017 Financial Results and Operational Highlights on November 27, 2017

20/11/2017 - 13:30

YARDLEY, Pa., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced that the Company will report its third [...]

Flexion Therapeutics Announces Full Commercial Launch and Nationwide Availability of ZILRETTA™ (triamcinolone acetonide extended-release injectable suspension)

20/11/2017 - 13:30

Recently approved, non-opioid therapy now available for the management of osteoarthritis knee pain Launch of ZILRETTA commences with full complement of field sales personnel deployed across the U.S. BURLINGTON, Mass., [...]

Geron Announces First Patient Dosed in Expanded Part 1 of IMerge Clinical Trial in Myelodysplastic Syndromes

20/11/2017 - 13:30

MENLO PARK, Calif., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN ) today announced that the first patient has been dosed in the expanded Part 1 of IMerge, the ongoing Phase 2/3 clinical trial of [...]

Beleave Announces $5 Million Non-Brokered Private Placement of Units

20/11/2017 - 13:25

TORONTO, Nov. 20, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. (" Beleave " or the " Company ") (CSE:BE) (OTCQX:BLEVF) is pleased to announce its intention to complete a non-brokered private placement (the " Non-Brokered [...]

THC Therapeutics in Partnership With ADVFN Announces Formation of New Company - MJAC Investorshub International Conferences Ltd

20/11/2017 - 13:20

LAS VEGAS, Nov. 20, 2017 (GLOBE NEWSWIRE) -- THC Therapeutics, Inc., Inc. (OTC:THCT) (“THCT” or the “Company”) announces that it has formed “MJAC InvestorsHub International Conferences Limited” (“MJAC LTD”) with ADVFN [...]

Summit Completes Initial 24 Weeks of Dosing of Ezutromid in Patients with DMD in PhaseOut DMD Clinical Trial

20/11/2017 - 13:01

Summit Therapeutics plc ("Summit" or the "Company") SUMMIT COMPLETES INITIAL 24 WEEKS OF DOSING OF EZUTROMID IN PATIENTS WITH DMD IN PhaseOut DMD CLINICAL TRIAL Summit Continues to Expect 24-week Data Q1 2018, which [...]